Formulation considerations for developing toothpastes suitable for those at risk from erosive tooth wear.
GlaxoSmithKline Consumer Healthcare Weybridge, Surrey, UK. Teresa.M.Layer@gsk.com
T M
TM
Layer
D017607:Aluminum Compounds; D001682:Biological Availability; D017610:Calcium Compounds; D005459:Fluorides / Q000493:pharmacokinetics; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012969:Sodium Fluoride / Q000627:therapeutic use*; D014077:Tooth Erosion / Q000517:prevention & control*; D014089:Tooth Remineralization / Q000379:methods*; D014100:Toothpastes / Q000138:chemical synthesis / Q000737:chemistry / Q000627:therapeutic use*
D017607:Aluminum Compounds; D017610:Calcium Compounds; D014100:Toothpastes; C035219:calcium aluminate; D012969:Sodium Fluoride; D005459:Fluorides